SUPRAX is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pharmpak, Inc.. The primary component is Cefixime.
Product ID | 54348-797_8f89a40f-a223-610f-e053-2a95a90ac727 |
NDC | 54348-797 |
Product Type | Human Prescription Drug |
Proprietary Name | SUPRAX |
Generic Name | Cefixime |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2019-07-12 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA065130 |
Labeler Name | PharmPak, Inc. |
Substance Name | CEFIXIME |
Active Ingredient Strength | 400 mg/1 |
Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-07-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA065130 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-07-12 |
Ingredient | Strength |
---|---|
CEFIXIME | 400 mg/1 |
SPL SET ID: | 3ba1c63c-64d9-4df9-ad62-61d4a9661218 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
27437-201 | SUPRAX | cefixime |
27437-203 | SUPRAX | cefixime |
27437-205 | SUPRAX | cefixime |
27437-206 | SUPRAX | cefixime |
27437-207 | SUPRAX | cefixime |
27437-208 | SUPRAX | cefixime |
43063-537 | SUPRAX | cefixime |
54348-797 | SUPRAX | CEFIXIME |
68180-202 | SUPRAX | SUPRAX |
70518-1020 | SUPRAX | SUPRAX |
70934-079 | SUPRAX | SUPRAX |
70518-2006 | SUPRAX | SUPRAX |
16714-766 | Cefixime | cefixime |
16714-767 | Cefixime | cefixime |
43598-673 | Cefixime | Cefixime |
43598-674 | Cefixime | Cefixime |
62250-663 | Cefixime | cefixime |
62250-664 | Cefixime | cefixime |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SUPRAX 86164468 4660961 Live/Registered |
Waterbrands, LLC 2014-01-13 |
SUPRAX 73707543 1500158 Dead/Cancelled |
AMERICAN CYANAMID COMPANY 1988-01-25 |
SUPRAX 73604097 1456050 Live/Registered |
AMERICAN CYANAMID COMPANY 1986-06-13 |